Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia

Clinical trial NCT06647888 · RECRUITING

Trial details

NCT number: NCT06647888
Sponsor: Daewoong Pharmaceutical Co. LTD.
Status: RECRUITING
Study type: OBSERVATIONAL

Diabetes Mellitus, Type 2

Start date: 2024-12-03
Primary completion: 2025-12-31
Enrollment: 12000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.